Raymond Joseph Tesi - 10 Jun 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Tesi Raymond Joseph
Issuer symbol
INMB
Transactions as of
10 Jun 2024
Net transactions value
$0
Form type
4
Filing time
12 Jun 2024, 16:30:48 UTC
Previous filing
16 May 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +37,882 $0.000000 37,882 10 Jun 2024 Common Stock 37,882 $8.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the INmune Bio Inc. 2021 Stock Incentive Plan. The option is 100% vested and exercisable as of the grant date.